Week In Review: Tasly Biopharma Completes Pre-IPO Round At $1.9 Billion Valuation
July 14, 2018 at 17:49 PM EDT
Tasly Biopharma (SHA: 600535) of Shanghai raised $84.5 million in new capital from a group of investors that included Ally Bridge. The funding is a pre-IPO round as Tasly is planning to list on the Hong Kong Exchange.
